Welcome to our dedicated page for Aehr Test Sys SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aehr Test Systems (NASDAQ: AEHR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a California-based supplier of semiconductor test and burn-in systems, Aehr uses these filings to report on financial performance, corporate governance, equity compensation plans, and other material events.
Investors can review current reports on Form 8-K, where Aehr discloses items such as quarterly and annual financial results, amendments to equity incentive and employee stock purchase plans, and outcomes of shareholder votes at its annual meetings. For example, recent 8-K filings describe the approval of amendments to the 2023 Equity Incentive Plan and the Amended and Restated 2006 Employee Stock Purchase Plan, as well as the ratification of the company’s independent registered public accounting firm.
The company’s proxy statement on Schedule DEF 14A provides detail on director elections, executive compensation proposals, advisory votes on pay and pay frequency, and the matters submitted to shareholders at the annual meeting. These documents help investors understand Aehr’s board structure, compensation programs, and shareholder voting results.
On Stock Titan, Aehr’s filings are updated in near real time from EDGAR. Users can access 8-Ks for earnings announcements and other material events, proxy materials for governance and compensation information, and related exhibits referenced in those filings. AI-powered summaries highlight key points, allowing readers to quickly see how developments in Aehr’s semiconductor test and burn-in business—spanning FOX wafer-level systems and Sonoma, Echo, and Tahoe package-level platforms—are reflected in its official disclosures.
Aehr Test Systems CFO Chris Siu reported the vesting of restricted stock units on 10/02/2025. To satisfy tax withholding on the vesting event, 694 shares were withheld at a price of $32.25, which the filer notes is not a sale. After the transaction the reporting person beneficially owns 75,535 shares directly and 5,211 shares indirectly through a trust; the total reported direct ownership figure includes shares subject to unvested restricted stock units. The Form 4 is a routine disclosure of an insider tax-withholding action tied to RSU vesting and does not indicate an open-market sale.
AEHR TEST SYSTEMS (AEHR) reporting person Vernon Rogers disclosed a change in beneficial ownership on 10/02/2025. The filing shows 299 shares of Common Stock were disposed of at a price of $32.25. The form explains those 299 shares were withheld to satisfy tax withholding obligations upon the vesting of restricted stock units and do not represent a sale by the reporting person. After the reported transaction, the reporting person beneficially owned 69,462 shares; this total includes shares subject to unvested restricted stock units.
Erickson Gayn, President and CEO and a director of Aehr Test Systems (AEHR), reported a withholding of 2,069 shares to satisfy tax obligations related to vested restricted stock units; the filing clarifies this withholding was not a sale. After the reported transaction, the reporting person directly holds 269,592 shares and indirectly holds 291,628 shares through a trust, with the indirect amount including unvested restricted stock units and restricted shares. The withheld shares were recorded at a price of $32.25 per share. The Form 4 discloses these non‑derivative changes and reiterates the ownership split between direct and indirect holdings.
Engineer Adil, listed as Chief Operating Officer of Aehr Test Systems (AEHR), filed a Form 4 reporting a transaction dated 10/02/2025. The filing shows 385 shares of common stock were disposed (Code F) at a price of $32.25 per share; the form explains these shares were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and do not represent a sale by the reporting person. After the transaction the reporting person beneficially owns 47,362 shares, an amount that includes shares subject to unvested restricted stock units. The filing was signed by an attorney-in-fact on 10/02/2025.
Didier Wimmers, Executive Vice President of R&D at Aehr Test Systems (AEHR), purchased 1,628 shares of AEHR common stock on 10/01/2025 at $6.6725 per share under the Company’s Amended and Restated 2006 Employee Stock Purchase Plan, which the filing notes is a tax-conditioned plan under IRC Section 423 and is exempt from Section 16 short-swing liability. After the purchase, the filing reports 14,921 total shares beneficially owned, an amount that the filer states includes shares subject to unvested restricted stock units. The Form 4 was filed by one reporting person and signed by an attorney-in-fact on behalf of the reporting person.
Insider purchase reported: Alberto Salamone, listed as Executive Vice President, PPBI Business, reported acquiring 184 shares of AEHR Test Systems common stock on 10/01/2025 at a price of $6.6725 per share under the company Amended and Restated 2006 Employee Stock Purchase Plan. The filing states the purchase is a tax-conditioned plan under Internal Revenue Code Section 423 and is exempt from Section 16 short-swing liability. After the transaction, Salamone is reported to beneficially own 78,533 shares, a total that includes shares subject to unvested restricted stock units. The Form 4 was executed by an attorney-in-fact, Chris Siu, on 10/01/2025.
AEHR Test Systems CFO Siu Chris reported insider activity on a Form 4 dated 10/01/2025. The filing shows an acquisition of 1,009 shares at a price of $6.6725 through the companys Amended and Restated 2006 Employee Stock Purchase Plan, which the filing states is a Section 423 tax-conditioned plan and exempt from six-month short-swing liability. The filing also records a disposition of 76,229 shares, and reports beneficial ownership of 5,211 shares following the transactions, held indirectly. The filing notes some reported shares include unvested restricted stock units. The signature on the form is "/s/ SIU CHRIS" dated 10/01/2025.
Engineer Adil, Chief Operating Officer of AEHR TEST SYSTEMS (AEHR), reported a purchase of 730 shares of the company's common stock on 10/01/2025 at a price of $6.6725 per share. The shares were acquired through the company's Amended and Restated 2006 Employee Stock Purchase Plan, a tax-conditioned plan under Internal Revenue Code Section 423, and this purchase is exempt from six-month short-swing liability under Section 16. Following the transaction, the reporting person beneficially owns 47,747 shares, an amount that includes shares subject to unvested restricted stock units.
Aehr Test Systems director Howard T. Slayen reported a change in beneficial ownership on 09/24/2025. The Form 4 shows a disposition of 5,000 shares of common stock, coded G, with a reported price of $0.00; the filing explains those shares were donated to Donor Advised Charitable Giving Inc. After the reported transaction the reporting person beneficially owned 224,328 shares, which the filer notes includes shares subject to unvested restricted stock units. The Form 4 was submitted by an attorney-in-fact and signed on 09/25/2025.
Aehr Test Systems describes its equity and executive compensation programs, including the 2023 Equity Incentive Plan, the Amended and Restated 2006 Employee Stock Purchase Plan (ESPP), and cash-based programs such as base salary, annual bonuses and commission plans. The filing explains award types available under the 2023 Plan—Nonqualified Stock Options, Incentive Stock Options, Restricted Stock, Restricted Stock Units, Stock Appreciation Rights, Performance Bonus Awards, Performance Stock Units and Dividend Equivalents—and summarizes their basic vesting, transfer and tax treatment.
The ESPP reserve and recent activity are disclosed: 209,594 shares remained available as of the record date; shares purchased in fiscal 2023, 2024 and 2025 were 210,765, 71,722 and 116,281, respectively; 86 employees participated in the most recent offering period purchasing 75,003 shares at an average purchase price of $6.6725 per share (value $7.85 on purchase date). Executive severance and change-in-control arrangements are described with specified cash multiples and continued healthcare and accelerated equity vesting for named executives.